211 related articles for article (PubMed ID: 28236450)
1. Evaluation of 4-thiazolidinone derivatives as potential reverse transcriptase inhibitors against HIV-1 drug resistant strains.
Suryawanshi R; Jadhav S; Makwana N; Desai D; Chaturbhuj D; Sonawani A; Idicula-Thomas S; Murugesan V; Katti SB; Tripathy S; Paranjape R; Kulkarni S
Bioorg Chem; 2017 Apr; 71():211-218. PubMed ID: 28236450
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular modeling studies of new 2,3-diheteroaryl thiazolidin-4-ones as NNRTIs.
Debnath U; Verma S; Singh P; Rawat K; Gupta SK; Tripathi RK; Siddiqui HH; Katti SB; Prabhakar YS
Chem Biol Drug Des; 2015 Nov; 86(5):1285-91. PubMed ID: 26031778
[TBL] [Abstract][Full Text] [Related]
3. F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis.
Lu X; Liu L; Zhang X; Lau TC; Tsui SK; Kang Y; Zheng P; Zheng B; Liu G; Chen Z
Antimicrob Agents Chemother; 2012 Jan; 56(1):341-51. PubMed ID: 22037848
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
Khalifa NM; Al-Omar MA
Int J Mol Sci; 2014 Nov; 15(11):20723-35. PubMed ID: 25397597
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
[TBL] [Abstract][Full Text] [Related]
6. Thiated derivatives of 2',3'-dideoxy-3'-fluorothymidine: synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms.
Miazga A; Hamy F; Louvel S; Klimkait T; Pietrusiewicz Z; Kurzyńska-Kokorniak A; Figlerowicz M; Wińska P; Kulikowski T
Antiviral Res; 2011 Oct; 92(1):57-63. PubMed ID: 21683097
[TBL] [Abstract][Full Text] [Related]
7. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
[TBL] [Abstract][Full Text] [Related]
10. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
[TBL] [Abstract][Full Text] [Related]
11. Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Devale TL; Parikh J; Miniyar P; Sharma P; Shrivastava B; Murumkar P
Bioorg Chem; 2017 Feb; 70():256-266. PubMed ID: 28160944
[TBL] [Abstract][Full Text] [Related]
12. The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
Xu G; Micklatcher M; Silvestri MA; Hartman TL; Burrier J; Osterling MC; Wargo H; Turpin JA; Buckheit RW; Cushman M
J Med Chem; 2001 Nov; 44(24):4092-113. PubMed ID: 11708913
[TBL] [Abstract][Full Text] [Related]
13. Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Murugesan V; Makwana N; Suryawanshi R; Saxena R; Tripathi R; Paranjape R; Kulkarni S; Katti SB
Bioorg Med Chem; 2014 Jun; 22(12):3159-70. PubMed ID: 24794742
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the research of 2,3-diaryl-1,3-thiazolidin-4-one derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Tian Y; Zhan P; Rai D; Zhang J; De Clercq E; Liu X
Curr Med Chem; 2012; 19(13):2026-37. PubMed ID: 22429098
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of naphthyl-substituted (B-ring) benzophenone derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ma XD; Zhang X; Dai HF; Yang SQ; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE
Bioorg Med Chem; 2011 Aug; 19(15):4601-7. PubMed ID: 21719299
[TBL] [Abstract][Full Text] [Related]
17. The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.
Xu W; Zhao J; Sun J; Yin Q; Wang Y; Jiao Y; Liu J; Jiang S; Shao Y; Wang X; Ma L
Antimicrob Agents Chemother; 2015 Aug; 59(8):4882-8. PubMed ID: 26055365
[TBL] [Abstract][Full Text] [Related]
18. Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.
Gu SX; Lu HH; Liu GY; Ju XL; Zhu YY
Eur J Med Chem; 2018 Oct; 158():371-392. PubMed ID: 30223123
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors.
Gawali R; Trivedi J; Bhansali S; Bhosale R; Sarkar D; Mitra D
Eur J Med Chem; 2018 Sep; 157():310-319. PubMed ID: 30099253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
